PMID: 8965363May 1, 1996Paper

Percutaneous ethanol injection therapy for small hepatocellular carcinoma

Nihon rinsho. Japanese journal of clinical medicine
S Otsuka

Abstract

Surgical resection is rarely indicated for hepatocellular carcinoma, because of its multiple lesions and often associated complication of liver cirrhosis. In 70-90% of patients who undergo radical operation, cancer will recur within 5 years after the surgery. Therefore, medical therapy plays an important role in the treatment for small hepatocellular carcinoma. Percutaneous ethanol injection therapy is thought to be the first choice, because of its excellent local control, preservation of liver function, and possibility of repeated use when necessary. We confirmed good long-term results of this therapy.

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.